- The US measles elimination status has been withdrawn by PAHO, after its commission found endemic transmission had been re-established.
- CDC Director Dr. Erica Schwartz said vaccination, not the designation, protects Americans. The agency has provided $100 million for state and local responses.
- MMR coverage among kindergartners dropped to 92.7%, from 95.2% prior to the pandemic, and the CDC says regaining status would require sustained national effort.
WASHINGTON — The United States officially lost its measles elimination status after the Pan American Health Organization withdrew the designation it had held for 26 years, and the CDC confirmed the decision in a joint statement released with its partners.
The withdrawal came after PAHO’s Re-Verification Commission recommended withdrawing the designation, concluding that endemic measles transmission had been re-established. PAHO Director Jarbas Barbosa accepted the recommendation, which also covered Mexico and Bolivia.
The confirmation follows Virginia Times’ November 14 report that officials had concluded the virus circulated continuously in the United States for more than a year, with more than 5,400 measles cases reported in 2026.
CDC Director Dr. Erica Schwartz said the designation itself was never the protection.
“The measles elimination designation is not what protects Americans. Vaccination does. We know where transmission is occurring and we’ve invested $100 million in state and local health departments to reach those communities. Losing a designation doesn’t mean we abandon an evidence-based approach. It means we remain focused on stopping outbreaks.”
Barbosa praised the American response even as the status was withdrawn. “We commend the significant efforts undertaken by the United States to manage the measles outbreak through strengthened surveillance, timely case detection and response, targeted vaccination activities, and coordination across the public health system,” he said.
The Effort to Regain the Status
Since August, the CDC has sent about $100 million to state and local health departments to strengthen measles prevention and response, funding that runs through most of 2027. About $50.2 million went to vaccine-preventable disease work and $49.8 million to epidemiology and laboratory capacity.
Federal Epi-Aid teams have deployed at the request of health departments in Texas, South Carolina, Virginia, Kansas, New Mexico and Wisconsin. Pennsylvania and New York have since asked for the same assistance.
The vaccination gaps that led to the resurgence show in the CDC’s own statistics. MMR coverage among kindergartners dropped from 95.2% for the 2019–2020 school year to 92.7% for 2023–2024.
Regaining the status, the CDC said, will require sustained national and state leadership and coordinated action across public health agencies, health care providers, laboratories and communities.
Also Read: US Loses Measles Elimination Status After 26 Years, Reports Say










